Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,998 | -15,805 | -11,456 | -7,508 | -3,812 |
| Depreciation Amortization | 25 | 100 | 75 | 50 | 25 |
| Accounts payable and accrued liabilities | -201 | 1,325 | 1,584 | 157 | 675 |
| Other Working Capital | -230 | 1,232 | 2,150 | 637 | 900 |
| Other Operating Activity | 535 | -394 | -858 | 384 | -381 |
| Operating Cash Flow | $-4,869 | $-13,541 | $-8,506 | $-6,281 | $-2,594 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 4,453 | N/A |
| Purchase Of Investment | -981 | -12,264 | N/A | N/A | N/A |
| Sale Of Investment | 5,100 | 7,986 | 6,991 | N/A | 2,770 |
| Investing Cash Flow | $4,119 | $-4,278 | $6,991 | $4,453 | $2,770 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 206 | 18,614 | 173 | 173 | 173 |
| Other Financing Activity | -150 | -600 | -450 | -300 | -150 |
| Financing Cash Flow | $56 | $18,014 | $-277 | $-127 | $23 |
| Exchange Rate Effect | 1 | -1 | N/A | N/A | N/A |
| Beginning Cash Position | 3,818 | 3,623 | 3,623 | 3,623 | 3,623 |
| End Cash Position | 3,125 | 3,818 | 1,831 | 1,669 | 3,822 |
| Net Cash Flow | $-694 | $195 | $-1,792 | $-1,955 | $199 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,869 | -13,541 | -8,506 | -6,281 | -2,594 |
| Free Cash Flow | -4,869 | -13,541 | -8,506 | -6,281 | -2,594 |